SynBiotic SE | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
SynBiotic SE

BRIEF

published on 11/14/2024 at 13:35, 6 days 20 hours ago

WEECO Pharma Acquisition Boosts SYNBIOTIC SE's Revenue

Acquisition Revenue Growth Medical Cannabis SYNBIOTIC SE WEECO Pharma
PRESS RELEASE

published on 11/14/2024 at 13:30, 6 days 21 hours ago

In full bloom: WEECO Pharma boosts SYNBIOTIC's sales
WEECO Pharma's acquisition by SYNBIOTIC SE significantly boosts sales, exceeding revenue targets for 2024. Substantial growth expected, fueling investor interest and expanding cannabis market presence

Acquisition Investor Relations Medical Cannabis SYNBIOTIC SE WEECO Pharma
BRIEF

published on 09/27/2024 at 11:24, 1 month 23 days ago

SynBiotic's Annual General Meeting Approves Growth Plans with Over 99% Approval

Annual General Meeting Strategic Growth Share Price Target Industrial Hemp Profitability 2025
PRESS RELEASE

published on 09/27/2024 at 11:19, 1 month 23 days ago

Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval
Annual General Meeting of SYNBIOTIC SE garners over 99% approval for growth plans targeting EUR 12.50 share price. Positive outlook fueled by strategic investments and market developments

Annual General Meeting Growth Plans Strategic Investments SYNBIOTIC SE EUR 12.50 Share Price
BRIEF

published on 09/17/2024 at 09:06, 2 months 4 days ago

Original-Research: SynBiotic SE Faces Promising Growth

Growth Strategy Cannabis Market Financial Outlook SYNBIOTIC SE Germany Regulations
PRESS RELEASE

published on 09/17/2024 at 09:01, 2 months 4 days ago

Original-Research: SynBiotic SE (von NuWays AG): BUY
SynBiotic SE sees growth potential in European hemp, cannabis, and cannabinoid markets. Expecting €40.8m sales by FY27e with focus on medical cannabis. Buy rating with €12.40 PT

BUY Rating Medical Cannabis Financial Growth SYNBIOTIC SE European Hemp
BRIEF

published on 08/16/2024 at 12:35, 3 months 4 days ago

SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing Sales Drive Growth

Cannabis Growth AGM 2024 SYNBIOTIC SE WEECO Pharma Hemp Sales
PRESS RELEASE

published on 08/16/2024 at 12:30, 3 months 4 days ago

SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth
SYNBIOTIC SE's Annual General Meeting on 20.09.2024 highlights sales growth with impressive results from WEECO Pharma, Hempro International, MH medical hemp, and CannaCare Health, reflecting positive outlook and strategic direction

Annual General Meeting Cannabis Industry Sales Growth SYNBIOTIC SE WEECO Pharma
BRIEF

published on 05/23/2024 at 10:36, 5 months 28 days ago

SYNBIOTIC SE and CEO Daniel Kruse Embark on European Roadshow

SYNBIOTIC SE Daniel Kruse Industrial Hemp EIHA Conference Mary Jane Expo
PRESS RELEASE

published on 05/23/2024 at 10:31, 5 months 29 days ago

Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow
SYNBIOTIC increases public presence with roadshow in Berlin and Prague, focusing on the potential of hemp and cannabis. CEO Daniel Kruse advocates for the removal of the 'intoxication clause' in Germany

Cannabis Hemp Roadshow SYNBIOTIC Daniel Kruse

Accesswire

Published on 11/21/2024 at 10:03, 29 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 32 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 32 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 57 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 7 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 27 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 30 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 32 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 32 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 31 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 34 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 12 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 47 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 47 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE